Biostage, Inc.
BSTGOTCHealthcare
$4.03
+$0.03(+0.75%)
Market Cap$57824048
P/E Ratio—
52W High$9.0
52W Low$3.65
Biostage, Inc. (BSTG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BSTG · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 13, 2023EPS Actual
-$0.12
Revenue
—
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 13, 2023
After Market Close
BSTG reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 10, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 28, 2024 | — | — | — | — | — | — |
| — Q4 FY2023 | Nov 13, 2023 | — | -$0.12 | — | — | — | — |
| — Q3 FY2023 | Aug 2, 2023 | — | -$0.19 | — | — | — | — |
| — Q2 FY2023 | May 12, 2023 | — | -$0.24 | — | — | — | — |
| — Q1 FY2023 | Mar 30, 2023 | — | -$0.12 | — | — | — | — |
| — Q4 FY2022 | Nov 14, 2022 | — | -$0.10 | — | — | — | — |
| — Q3 FY2022 | Aug 4, 2022 | — | -$0.12 | — | — | — | — |
Q2 FY2024
May 10, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 2, 2023
EPS Actual
-$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 12, 2023
EPS Actual
-$0.24
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Mar 30, 2023
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Nov 14, 2022
EPS Actual
-$0.10
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2022
Aug 4, 2022
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for BSTG.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Nov 13, 2023 | — | $3.95 | — | — |
| — Q3 FY2023 | Aug 2, 2023 | — | $4.03 | $3.95 | -1.99% |
| — Q2 FY2023 | May 12, 2023 | — | $6.02 | $5.81 | -3.49% |
| — Q1 FY2023 | Mar 30, 2023 | — | $6.10 | $6.15 | +0.82% |
| — Q4 FY2022 | Nov 14, 2022 | — | $6.19 | $6.90 | +11.48% |
| — Q3 FY2022 | Aug 4, 2022 | — | $5.40 | $5.00 | -7.41% |
| — Q2 FY2022 | May 16, 2022 | — | $5.50 | $5.50 | +0.00% |
| — Q2 FY2022 | Apr 1, 2022 | — | $4.90 | $4.90 | +0.00% |
Q4 FY2023—
Report Date
Nov 13, 2023
EPS Beat/Miss
—
Price Before
$3.95
Price After
—
Q3 FY2023-1.99%
Report Date
Aug 2, 2023
EPS Beat/Miss
—
Price Before
$4.03
Price After
$3.95
Q2 FY2023-3.49%
Report Date
May 12, 2023
EPS Beat/Miss
—
Price Before
$6.02
Price After
$5.81
Q1 FY2023+0.82%
Report Date
Mar 30, 2023
EPS Beat/Miss
—
Price Before
$6.10
Price After
$6.15
Q4 FY2022+11.48%
Report Date
Nov 14, 2022
EPS Beat/Miss
—
Price Before
$6.19
Price After
$6.90
Q3 FY2022-7.41%
Report Date
Aug 4, 2022
EPS Beat/Miss
—
Price Before
$5.40
Price After
$5.00
Q2 FY2022+0.00%
Report Date
May 16, 2022
EPS Beat/Miss
—
Price Before
$5.50
Price After
$5.50
Q2 FY2022+0.00%
Report Date
Apr 1, 2022
EPS Beat/Miss
—
Price Before
$4.90
Price After
$4.90
Beat Rate0 / 8 quarters
Largest Move+11.48% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BSTG ends December
Biostage, Inc. (BSTG) most recently reported earnings on November 13, 2023 for Q4 FY2023, posting EPS of $-0.12 (in line with the analyst consensus of —). The next BSTG earnings date is expected around September 1, 2026.
Each quarter, investors track BSTG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BSTG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BSTG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BSTG earnings · 4 questionsBiostage, Inc.'s next earnings report is expected around September 1, 2026. BSTG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BSTG historically reports after market close (AMC).
BSTG earnings datewhen is BSTG earningsBSTG next earnings datewhen does BSTG report earningsBSTG earnings calendar
▸ Source: FMP · Biostage, Inc. SEC filings · US GAAP · Biostage, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026